| Enhertu granted BTD for post-neoadjuvant early BC | 22-Dec-2025 | ShareCast |
| Update on LATIFY Phase III trial of ceralasertib | 22-Dec-2025 | ShareCast |
| Director/PDMR Shareholding | 19-Dec-2025 | ShareCast |
| Germany's Cheplapharm pays AstraZeneca $200m for... | 01-Oct-2018 | ShareCast |
| Sunday share tips: AstraZeneca, Genus, 'Dogs of ... | 30-Jul-2017 | ShareCast |
| Director/PDMR Shareholding | 22-Dec-2025 | 11:00 | RNS |
| Enhertu granted BTD for post-neoadjuvant early BC | 22-Dec-2025 | 07:30 | RNS |
| Update on LATIFY Phase III trial of ceralasertib | 22-Dec-2025 | 07:00 | RNS |
| Director/PDMR Shareholding | 19-Dec-2025 | 11:00 | RNS |
| Questor :AstraZeneca | 29-Apr-2014 | Telegraph |
| Questor : AstraZeneca | 24-Jan-2014 | Telegraph |
| Questor:AstraZeneca | 22-Dec-2011 | Telegraph |
| Investment Column:AstraZeneca | 28-Oct-2011 | The Independent |
| Investment Column: AstraZeneca | 23-Jun-2011 | The Independent |
| Currency | UK Pounds |
| Share Price | 13,394.00p |
| Change Today | -2.40p |
| % Change | -1.76 % |
| 52 Week High | 14,156.00 |
| 52 Week Low | 9,642.00 |
| Volume | 395,850 |
| Shares Issued | 1,264.16m |
| Market Cap | £169,322m |
| Strong Buy | 10 |
| Buy | 13 |
| Neutral | 3 |
| Sell | 0 |
| Strong Sell | 1 |
| Total | 27 |

| Time | Volume / Share Price |
| 16:29 | 5 @ 13,394.00p |
| 16:29 | 91 @ 13,392.00p |
| 16:29 | 30 @ 13,392.00p |
| 16:29 | 35 @ 13,390.00p |
| 16:29 | 88 @ 13,390.00p |
You are here: research